In conclusion, the in vitro evaluation of healthy primary human T cells and TILs isolated form ovarian cancer patients confirmed GPR56 expression on both populations, with the latter displaying the highest expression levels, combined with a predominantly TEM and TCM phenotype that expressed key proteins identified from the scRNAseq analysis. This evidence concerns the gene ADGRG1 and ovarian carcinoma.